Literature DB >> 3524244

Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies.

J Jonas, K Kölble, H E Völcker, J R Kalden.   

Abstract

A 33-year-old woman with retinal artery occlusion also had Sneddon's disease (livedo reticularis, neurologic abnormalities, and labile hypertension). While retinal artery occlusive disease obviously must be added to the symptomatic spectrum of this rare disorder, the detection of antiphospholipid antibodies in this patient has pathogenetic implications.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3524244     DOI： 10.1016/0002-9394(86)90206-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


  14 in total

1.  Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

Authors:  F Y Demirci; R Küçükkaya; K Akarçay; N Kir; T Atamer; H Demirci; E Ongör
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Occlusive ocular vascular disease and antiphospholipid antibodies.

Authors:  C Tolosa-Vilella; J Ordi-Ros; R Jordana-Comajuncosa; A Selva-O'Callaghan; M Vilardell-Tarres
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

3.  Retinal migraine, chorea, and retinal artery thrombosis in a patient with primary antiphospholipid antibody syndrome.

Authors:  J A Gutrecht; N Kattwinkel; M J Stillman
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

Review 4.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 5.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

Review 6.  Anticardiolipin antibodies and cardiovascular disease.

Authors:  K W Muir
Journal:  J R Soc Med       Date:  1995-08       Impact factor: 5.344

7.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

8.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

Authors:  R A Asherson; P Merry; J F Acheson; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

Review 9.  Retinal vasculitis--a primer.

Authors:  J T Rosenbaum; J E Robertson; R C Watzke
Journal:  West J Med       Date:  1991-02

Review 10.  The management of acute visual failure.

Authors:  S H Wray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.